Literature DB >> 18413815

Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.

Johannes A Mayr1, David Meierhofer, Franz Zimmermann, Rene Feichtinger, Christian Kögler, Manfred Ratschek, Nikolaus Schmeller, Wolfgang Sperl, Barbara Kofler.   

Abstract

PURPOSE: Many solid tumors exhibit abnormal aerobic metabolism characterized by increased glycolytic capacity and decreased cellular respiration. Recently, mutations in the nuclear encoded mitochondrial enzymes fumarate hydratase and succinate dehydrogenase have been identified in certain tumor types, thus demonstrating a direct link between mitochondrial energy metabolism and tumorigenesis. Although mutations in the mitochondrial genome (mitochondrial DNA, mtDNA) also can affect aerobic metabolism and mtDNA alterations are frequently observed in tumor cells, evidence linking respiratory chain deficiency in a specific tumor type to a specific mtDNA mutation has been lacking. EXPERIMENTAL
DESIGN: To identify mitochondrial alterations in oncocytomas, we investigated the activities of respiratory chain enzymes and sequenced mtDNA in 15 renal oncocytoma tissues.
RESULTS: Here, we show that loss of respiratory chain complex I (NADH/ubiquinone oxidoreductase) is associated with renal oncocytoma. Enzymatic activity of complex I was undetectable or greatly reduced in the tumor samples (n = 15). Blue Native gel electrophoresis of the multisubunit enzyme complex revealed a lack of assembled complex I. Mutation analysis of the mtDNA showed frame-shift mutations in the genes of either subunit ND1, ND4, or ND5 of complex I in 9 of the 15 tumors.
CONCLUSION: Our data indicate that isolated loss of complex I is a specific feature of renal oncocytoma and that this deficiency is frequently caused by somatic mtDNA mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413815     DOI: 10.1158/1078-0432.CCR-07-4131

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  65 in total

1.  High-resolution genomic profiling of thyroid lesions uncovers preferential copy number gains affecting mitochondrial biogenesis loci in the oncocytic variants.

Authors:  Ivana Kurelac; Dario de Biase; Claudia Calabrese; Claudio Ceccarelli; Charlotte Ky Ng; Raymond Lim; Alan MacKay; Britta Weigelt; Anna Maria Porcelli; Jorge S Reis-Filho; Giovanni Tallini; Giuseppe Gasparre
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

2.  The somatic genomic landscape of chromophobe renal cell carcinoma.

Authors:  Caleb F Davis; Christopher J Ricketts; Min Wang; Lixing Yang; Andrew D Cherniack; Hui Shen; Christian Buhay; Hyojin Kang; Sang Cheol Kim; Catherine C Fahey; Kathryn E Hacker; Gyan Bhanot; Dmitry A Gordenin; Andy Chu; Preethi H Gunaratne; Michael Biehl; Sahil Seth; Benny A Kaipparettu; Christopher A Bristow; Lawrence A Donehower; Eric M Wallen; Angela B Smith; Satish K Tickoo; Pheroze Tamboli; Victor Reuter; Laura S Schmidt; James J Hsieh; Toni K Choueiri; A Ari Hakimi; Lynda Chin; Matthew Meyerson; Raju Kucherlapati; Woong-Yang Park; A Gordon Robertson; Peter W Laird; Elizabeth P Henske; David J Kwiatkowski; Peter J Park; Margaret Morgan; Brian Shuch; Donna Muzny; David A Wheeler; W Marston Linehan; Richard A Gibbs; W Kimryn Rathmell; Chad J Creighton
Journal:  Cancer Cell       Date:  2014-08-21       Impact factor: 31.743

Review 3.  Renal cell carcinoma deep sequencing: recent developments.

Authors:  Leslie J Farber; Kyle Furge; Bin Tean Teh
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

Review 4.  Mitochondria and cancer.

Authors:  Valdemar Máximo; Jorge Lima; Paula Soares; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2009-04-03       Impact factor: 4.064

5.  Mitochondrial biogenesis drives tumor cell proliferation.

Authors:  Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Federica Sotgia; Michael P Lisanti
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

6.  Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates.

Authors:  Sarah McMahon; Thomas LaFramboise
Journal:  Carcinogenesis       Date:  2014-01-18       Impact factor: 4.944

7.  Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression.

Authors:  Antonio F Santidrian; Akemi Matsuno-Yagi; Melissa Ritland; Byoung B Seo; Sarah E LeBoeuf; Laurie J Gay; Takao Yagi; Brunhilde Felding-Habermann
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

8.  Analysis of differentially expressed mitochondrial proteins in chromophobe renal cell carcinomas and renal oncocytomas by 2-D gel electrophoresis.

Authors:  Maria V Yusenko; Thomas Ruppert; Gyula Kovacs
Journal:  Int J Biol Sci       Date:  2010-04-23       Impact factor: 6.580

9.  Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma.

Authors:  Rene' G Feichtinger; Franz Zimmermann; Johannes A Mayr; Daniel Neureiter; Cornelia Hauser-Kronberger; Freimut H Schilling; Neil Jones; Wolfgang Sperl; Barbara Kofler
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

10.  Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.

Authors:  Hisashi Hasumi; Masaya Baba; Yukiko Hasumi; Ying Huang; Hyoungbin Oh; Robert M Hughes; Mara E Klein; Shoichi Takikita; Kunio Nagashima; Laura S Schmidt; W Marston Linehan
Journal:  J Natl Cancer Inst       Date:  2012-11-12       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.